文献速递临床试验与 GCP基础与转化研究

乌克兰简短版共同要素治疗方法(CETA)有效性与实施随机对照试验研究方案

Testing the effectiveness and implementation of a brief version of the Common Elements Treatment Approach (CETA) in Ukraine: a study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-08-03

该试验采用非劣效性设计,在乌克兰比较简短版CETA(5次)与标准版CETA(8-12次)对抑郁、创伤后应激、功能受损、焦虑和物质使用问题的疗效,并设等待名单对照组。主要假设为简短版CETA疗效不劣于标准版,且两版均优于对照组,主要效应采用6个月内纵向数据和混合效应回归模型评估。

要点

  • 简短版CETA(5次)旨在非劣效于标准版CETA(8-12次)改善常见精神健康问题严重程度。
  • 简短版与标准版CETA均预期优于等待名单对照组。
  • 主要效应采用基线后6个月内纵向数据和混合效应回归模型评估。

核心结论

  • 该试验将检验简短版CETA在减少常见精神健康问题严重程度上是否非劣效于标准版CETA,以及两版CETA是否均优于等待名单对照。

研究设计与样本

  • 随机对照试验,采用非劣效性设计,比较简短版CETA(5次)与标准版CETA(8-12次),并设等待名单对照条件。
  • 主要效应采用基线后6个月内的纵向数据和混合效应回归模型评估。

关键数值与推荐

  • 主要假设1:简短版CETA(5次)在减少抑郁、创伤后应激、功能受损、焦虑和物质使用问题严重程度上与标准版CETA(8-12次)疗效相似。
  • 主要假设2:简短版和标准版CETA对结局的影响均优于等待名单对照条件。

临床怎么用

  • 若简短版CETA被证实非劣效,可为资源有限环境提供更可扩展的模块化、灵活、跨诊断认知行为治疗方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mental illness is a major public health concern. Despite progress understanding which treatments work, a significant treatment gap remains. An ongoing concern is treatment length. Modular, flexible, transdiagnostic approaches have been offered as one solution to scalability challenges. The Common Elements Treatment Approach (CETA) is one such approach and offers the ability to treat a wide range of common mental health problems. CETA is supported by two randomized trials from low- and middle-income countries showing strong effectiveness and implementation outcomes. METHODS/DESIGN: This trial evaluates the effectiveness and implementation of two versions of CETA using a non-inferiority design to test two primary hypotheses: (1) a brief five-session version of CETA (Brief CETA) will provide similar effectiveness for reducing the severity of common mental health problems such as depression, post-traumatic stress, impaired functioning, anxiety, and substance use problems compared with the standard 8-12-session version of CETA (Standard CETA); and (2) both Brief and Standard CETA will have superior impact on the outcomes compared to a wait-list control condition. For both hypotheses, the main effect will be assessed using longitudinal data and mixed-effects regression models over a 6-month period post baseline. A secondary aim includes exploration of implementation factors. Additional planned analyses will include exploration of: moderators of treatment impact by disorder severity and comorbidity; the impact of individual therapeutic components; and trends in symptom change between end of treatment and 6-month assessment for all participants. DISCUSSION: This trial is the first rigorous study comparing a standard-length (8-12 sessions) modular, flexible, transdiagnostic, cognitive-behavioral approach to a shortened version of the approach (five sessions). Brief CETA entails "front-loading" with elements that research suggests are strong mechanisms of change. The study design will allow us to draw conclusions about the effects of both Brief and Standard CETA as well as which elements are integral to their mechanisms of action, informing future implementation and fidelity efforts. The results from this trial will inform future dissemination, implementation and scale-up of CETA in Ukraine and contribute to our understanding of the effects of modular, flexible, transdiagnostic approaches in similar contexts. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT03058302 (U.S. National Library of Medicine). Registered on 20 February 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Murray LK, Haroz EE, Doty B, et al. Testing the effectiveness and implementation of a brief version of the Common Elements Treatment Approach (CETA) in Ukraine: a study protocol for a randomized controlled trial. Trials. 2018. PMID: 30075806. doi:10.1186/s13063-018-2752-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。